Trial Profile
Phase II Clinical Trial of CPI 613 in Patients With Locally Advanced or Metastatic Pancreatic Cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 12 Nov 2013
Price :
$35
*
At a glance
- Drugs Devimistat (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- Sponsors Cornerstone Pharmaceuticals Inc
- 12 Nov 2013 New trial record